Long-Term Urologic Evaluation Following Spinal Cord Injury

被引：0
作者：
Stothers L. [1 ,2 ,3 ]
Locke J.A. [2 ]
Macnab A. [2 ]
Nigro M. [1 ,2 ]
机构：
[1] International Collaboration on Repair Discoveries (ICORD), Faculty of Medicine, University of British Columbia, 818 W. 10th Avenue, Vancouver, V5Z, BC
[2] Department of Urologic Sciences, Gordon and Leslie Diamond Health Care Centre, University of British Columbia, Level 6, 2775 Laurel Street, Vancouver
[3] Department of Obstetrics and Gynaecology, School of Population and Public Health, University of British Columbia, Vancouver, BC
来源：
Current Bladder Dysfunction Reports | 2016年 / 11卷 / 2期
关键词：
Autonomic dysreflexia; Lower urinary tract symptoms; Neurogenic bladder; Urodynamics;
D O I：
10.1007/s11884-016-0367-2
中图分类号：
学科分类号：
摘要：
Spinal cord injury (SCI) has significant long-term urologic consequences that impact quality of life (QOL) and can influence life expectancy. Neurogenic bladder, urinary tract infections, and autonomic dysreflexia are common consequences of SCI. It is essential to conduct a focused patient interview to address these consequences. History should include a basic assessment of the patient and symptomatology as per a validated instrument, as well as a detailed urologic diary. The physical examination should include evaluation of the extent of the neurologic injury as per the American Spinal Association Injury (ASIA) scale, the affected system as well as examination maneuvers done in those without neurologic injury. Investigations should include urodynamic testing and cystoscopy. In managing patients with SCI, pharmaceutical agents and intermittent catheterization are utilized normally in an effort to protect the upper urinary tract, achieve and maintain urinary continence, and optimize lower urinary tract function and quality of life (QOL). © 2016, Springer Science+Business Media New York.
引用
收藏
页码：169 / 180
页数：11
相关论文
共 110 条
[51]  
del Popolo G., Mencarini M., Nelli F., Lazzeri M., Controversy over the pharmacological treatments of storage symptoms in spinal cord injury patients: a literature overview, Spinal Cord, 50, pp. 8-13, (2012)
[52]  
Amend B., Hennenlotter J., Schafer T., Horstmann M., Stenzl A., Sievert K.D., Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects, Eur Urol, 53, pp. 1021-1028, (2008)
[53]  
Bennett N., O'Leary M., Patel A.S., Xavier M., Erickson J.R., Chancellor M.B., Can higher doses of oxybutynin improve efficacy in neurogenic bladder?, J Urol, 171, pp. 749-751, (2004)
[54]  
Igawa Y., Aizawa N., Homma Y., Beta3-adrenoceptor agonists: possible role in the treatment of overactive bladder, Korean J Urol, 51, pp. 811-818, (2010)
[55]  
Andersson K.E., Martin N., Nitti V., Selective beta(3)-adrenoceptor agonists for the treatment of overactive bladder, J Urol, 190, pp. 1173-1180, (2013)
[56]  
Rossanese M., Novara G., Challacombe B., Iannetti A., Dasgupta P., Ficarra V., Critical analysis of phase II and III randomised control trials (RCTs) evaluating efficacy and tolerability of a beta(3)-adrenoceptor agonist (mirabegron) for overactive bladder (OAB), BJU Int, 115, pp. 32-40, (2015)
[57]  
Apostolidis A., Taming the cannabinoids: new potential in the pharmacologic control of lower urinary tract dysfunction, Eur Urol, 61, pp. 107-109, (2012)
[58]  
Abrams P., Amarenco G., Bakke A., Et al., Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury, J Urol, 170, pp. 1242-1251, (2003)
[59]  
Reid G., Hsiehl J., Potter P., Et al., Cranberry juice consumption may reduce biofilms on uroepithelial cells: pilot study in spinal cord injured patients, Spinal Cord, 39, pp. 26-30, (2001)
[60]  
Opperman E.A., Cranberry is not effective for the prevention or treatment of urinary tract infections in individuals with spinal cord injury, Spinal Cord, 48, pp. 451-456, (2010)
12345678910